Clinical Trial Update: Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin [Phase 2]

View source ↗

Summary

Phase II trial of erlotinib given prior to surgery or radiation in patients with squamous cell carcinoma of the skin; the study was terminated and results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Skin

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Skin Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-04-04